Multiple Myeloma Cure

Multiple myeloma cure - The incidence of venous thromboembolism (VTE) in patients with multiple myeloma (MM) is a significant increase in the risk of VTE increases even more during the induction chemotherapy, especially when using a combination of thalidomide or lenalidomide with prednisone, and dexamethasone to high dose, while therapy comprising bortezomib no potential thrombotic complications.